Am J Psychiatry 157:1-2, January 2000
© 2000 American Psychiatric Association
Distributed Disturbances in Brain Structure and Function in Schizophrenia
Models of the nature of brain dysfunction in major psychiatric disorders have evolved substantially over the past several decades in parallel with (if lagging somewhat behind) the progression in knowledge resulting from investigations of the biological mechanisms that contribute to normal cognition, emotion, and behavior. Previous models of psychopathology frequently emphasized, in their simplest forms, the central contribution of either 1) excesses or deficits in the amount of a given neurotransmitter (in some cases, these models bore more than a superficial resemblance to historical beliefs that altered levels of the four classical bodily humors produced different forms of madness) or 2) a localized disturbance in the structure of a single brain region (an approach that, in extreme cases, could be considered a twentieth-century variant of phrenology). These ideas have given way to a fuller appreciation of the fact that neurotransmitters act in an anatomically constrained fashion to produce specific biochemical effects at the cellular level and the fact that the localization of function(s) is a consequence of the flow of information processing through the neural circuits within a given brain region and those linking that region to other brain areas. Indeed, Braff (1) has observed that the newer literature (see references 2–4 for examples) reflects a movement from "one neurotransmitter, one locus" models of psychopathology to formulations that "invoke wide-ranging anatomical sites of dysfunction with accompanying abnormal connectivity." These latter types of models incorporate the recognition that complex brain functions, such as those that are disturbed in major psychiatric disorders, are subserved by the integrated activity of distributed ensembles of neurons.
Three studies of schizophrenia reported in this issue of the Journal provide illustrations of the relations between empirical studies and these newer models of pathophysiology. Vogeley and colleagues report that the gyrification index, a measure of the degree of cortical folding, is significantly higher than normal, by an average of 7%, in the right prefrontal cortex of male subjects with schizophrenia. McDonald et al. describe 10%–13% lower than normal mean volumes of the left hippocampal and fusiform gyri of the temporal lobe, and an associated reversal of the normal left-greater-than-right volume asymmetry of these brain regions, in subjects with schizophrenia. These findings are of interest for several reasons. First, they converge with, and extend, the results of previous studies demonstrating modest volumetric abnormalities in the prefrontal and medial temporal lobes of subjects with schizophrenia (see references 5 and 6 for reviews). Second, the nature of the reported findings point to possible mechanisms as to how these abnormalities arise. However, these studies also raise the questions of how such abnormalities in different brain regions are related to each other and how they actually contribute to the clinical phenomena of schizophrenia.
In the third study, Bertolino and associates used a novel approach to address these types of questions. These investigators combined spectroscopic magnetic resonance imaging of N-acetylaspartate, a surrogate marker of neuronal integrity, with PET images obtained while subjects performed tasks that tap working memory. Their results confirm that working memory tasks require the activation of a neuronal network distributed across a number of cortical and subcortical structures (7, 8). More important, their findings suggest that the function of the network can be disrupted by a disturbance in neuronal integrity (e.g., decreased N-acetylaspartate levels) that appears to be restricted to one node of the network, in this case the dorsolateral prefrontal cortex. However, the authors carefully point out that abnormal N-acetylaspartate levels could reflect focal pathological changes either of neurons intrinsic to the prefrontal cortex or of afferent inputs from the thalamus, medial temporal lobe, or other brain region. Indeed, these options are not mutually exclusive, and an either/or scenario actually seems unlikely. By virtue of the interconnections among nodes, it would be surprising if a disturbance in one region did not produce a series of alterations throughout the network, ranging from shifts in gene expression to larger-scale structural changes. In terms of the Bertolino et al. study, it may be that disturbances in multiple projection streams crossed the threshold of detectability in the prefrontal cortex, only by virtue of their confluence in that brain region.
Given the probability that distributed network models of brain dysfunction in schizophrenia (and other psychiatric disorders) will continue to improve our ability to account for clinical observations, a critical next step will involve disentangling the relations among the abnormalities observed in different brain areas. Specifically, understanding the pathophysiology of a given disorder will ultimately require an appreciation of how abnormalities in one brain region produce and/or result from disturbances in other brain areas, a task that involves a consideration of the "three Cs": cause, consequence, and compensation. Does a given abnormality represent the primary brain disturbance (cause), does it reflect a downstream or upstream (given the reciprocal nature of many links between brain regions), secondary, deleterious event (consequence), or does it reveal a homeostatic response designed to restore (at least partially) normal brain function (compensation)? Distinguishing among these three possibilities for each component of a neural network will be essential in a number of respects, including the development of novel therapies designed to correct causes and consequences and/or to augment compensatory responses.
FOOTNOTES
Address reprint requests to Dr. Lewis, Department of Psychiatry, University of Pittsburgh, W1650 Biomedical Science Tower, 3811 O’Hara St., Pittsburgh, PA 15213; lewisda{at}msx.upmc.edu (e-mail).
REFERENCES
-
Braff DL: Connecting the "dots" of brain dysfunction in schizophrenia: what does the picture look like? Arch Gen Psychiatry 1999; 56:791–793
-
Andreasen NC, O’Leary DS, Cizadlo T, Arndt S, Rezai K, Boles Ponto LL, Watkins GL, Hichwa RD: Schizophrenia and cognitive dysmetria: a positron-emission tomography study of dysfunctional prefrontal-thalamic-cerebellar circuitry. Proc Natl Acad Sci USA 1996; 93:9985–9990[Abstract/Free Full Text]
-
Jones EG: Cortical development and thalamic pathology in schizophrenia. Schizophr Bull 1997; 23:483–501
-
Weinberger DR: Anteromedial temporal-prefrontal connectivity: a functional neuroanatomical system implicated in schizophrenia, in Psychopathology and the Brain. Edited by Carroll BJ, Barrett JE. New York, Raven Press, 1991, pp 25–41
-
McCarley RW, Wible CG, Frumin M, Hirayasu Y, Levitt JJ, Fischer IA, Shenton ME: MRI anatomy of schizophrenia. Biol Psychiatry 1999; 45:1099–1119
-
Harrison PJ: The neuropathology of schizophrenia: a critical review of the data and their interpretation. Brain 1999; 122:593–624[Abstract/Free Full Text]
-
Goldman-Rakic PS: Topography of cognition: parallel distributed networks in primate association cortex. Annu Rev Neurosci 1988; 11:137–156[CrossRef][Medline]
-
Ungerleider LG, Courtney SM, Haxby JV: A neural system for human visual working memory. Proc Natl Acad Sci USA 1998; 95:883–890[Abstract/Free Full Text]
This article has been cited by other articles:
|
|
|
|
 
D. Deshauer MD MSc, D. Moher PhD, D. Fergusson PhD, E. Moher BA, M. Sampson MLIS, and J. Grimshaw MD PhD
Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials
Can. Med. Assoc. J.,
May 6, 2008;
178(10):
1293 - 1301.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. L. Kramer, T. L. Miller, S. D. Phillips, and J. M. Robbins
Quality of Mental Health Care for Depressed Adolescents
American Journal of Medical Quality,
April 1, 2008;
23(2):
96 - 104.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. Timonen and T. Liukkonen
Management of depression in adults
BMJ,
February 23, 2008;
336(7641):
435 - 439.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. M. Horgan, E. L. Merrick, M. T. Stewart, S. H. Scholle, and S. Shih
Improving Medication Management of Depression in Health Plans
Psychiatr Serv,
January 1, 2008;
59(1):
72 - 77.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Fochtmann, F. F. Duffy, J. C. West, R. Kunkle, and R. M. Plovnick
Performance in Practice: Sample Tools for the Care of Patients with Major Depressive Disorder
Focus,
January 1, 2008;
6(1):
22 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. H. Levine and R. C. Albucher
Patient Management Exercise: Major Depressive Disorder and Suicide
Focus,
January 1, 2008;
6(1):
47 - 57.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, A. A. Nierenberg, J. W. Stewart, D. Warden, G. Niederehe, M. E. Thase, P. W. Lavori, B. D. Lebowitz, et al.
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
Focus,
January 1, 2008;
6(1):
128 - 142.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. S. Mayberg, A. M. Lozano, V. Voon, H. E. McNeely, D. Seminowicz, C. Hamani, J. M. Schwalb, and S. H. Kennedy
Deep Brain Stimulation for Treatment-Resistant Depression
Focus,
January 1, 2008;
6(1):
143 - 154.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Aikens, D. E. Nease Jr, and M. S. Klinkman
Explaining Patients' Beliefs About the Necessity and Harmfulness of Antidepressants
Ann. Fam. Med,
January 1, 2008;
6(1):
23 - 29.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. W. Van Voorhees, A. E. Walters, M. Prochaska, and M. T. Quinn
Reducing Health Disparities in Depressive Disorders Outcomes between Non-Hispanic Whites and Ethnic Minorities: A Call for Pragmatic Strategies over the Life Course
Med Care Res Rev,
October 1, 2007;
64(5_suppl):
157S - 194S.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. A. Blumenthal, M. A. Babyak, P. M. Doraiswamy, L. Watkins, B. M. Hoffman, K. A. Barbour, S. Herman, W. E. Craighead, A. L. Brosse, R. Waugh, et al.
Exercise and Pharmacotherapy in the Treatment of Major Depressive Disorder
Psychosom Med,
September 1, 2007;
69(7):
587 - 596.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. S. Hoffer, S. L. Allen, and M. Mathews
Treatment of Psychiatric Symptoms Associated With a Frontal Lobe Tumor Through Surgical Resection
Am J Psychiatry,
June 1, 2007;
164(6):
877 - 882.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. P. van MELLE, P. de JONGE, A. HONIG, A. H. SCHENE, A. M. G. KUYPER, H. J. G. M. CRIJNS, A. SCHINS, D. TULNER, M. P. van den BERG, and J. ORMEL
Effects of antidepressant treatment following myocardial infarction
The British Journal of Psychiatry,
June 1, 2007;
190(6):
460 - 466.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. S. Williams, K. Kroenke, T. Bakas, L. D. Plue, E. Brizendine, W. Tu, and H. Hendrie
Care Management of Poststroke Depression: A Randomized, Controlled Trial
Stroke,
March 1, 2007;
38(3):
998 - 1003.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Beyer, L. Taylor, K. R. Gersing, and K. R. R. Krishnan
Prevalence of HIV Infection in a General Psychiatric Outpatient Population
Psychosomatics,
February 1, 2007;
48(1):
31 - 37.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. M. Koran M.D.
Obsessive-Compulsive Disorder: An Update for the Clinician
Focus,
January 1, 2007;
5(3):
299 - 313.
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. D. Kirkcaldy and L. L. Tynes
Best Practices: Depression Screening in a VA Primary Care Clinic
Psychiatr Serv,
December 1, 2006;
57(12):
1694 - 1696.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Fassino, A. Piero, C. Gramaglia, G. A. Daga, M. Gandione, G. G. Rovera, and G. Bartocci
Clinical, Psychological, and Personality Correlates of Asceticism in Anorexia Nervosa: From Saint Anorexia to Pathologic Perfectionism
Transcultural Psychiatry,
December 1, 2006;
43(4):
600 - 614.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. J. Lee, E. Proctor, and N. Morrow-Howell
Depression Outcomes and Quality of Postdischarge Care of Elders Hospitalized for Major Depression
Psychiatr Serv,
October 1, 2006;
57(10):
1446 - 1451.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. G. RUHE, J. HUYSER, J. A. SWINKELS, and A. H. SCHENE
Dose escalation for insufficient response to standard-dose selective serotonin reuptake inhibitors in major depressive disorder: Systematic review
The British Journal of Psychiatry,
October 1, 2006;
189(4):
309 - 316.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Adler, T. J. McLaughlin, W. H. Rogers, H. Chang, L. Lapitsky, and D. Lerner
Job Performance Deficits Due to Depression
Am J Psychiatry,
September 1, 2006;
163(9):
1569 - 1576.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S.-Y. Chen, C. Jordan, and S. Thompson
The Effect of Cognitive Behavioral Therapy (CBT) on Depression: The Role of Problem-Solving Appraisal
Research on Social Work Practice,
September 1, 2006;
16(5):
500 - 510.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. W. Lam, A. J. Levitt, R. D. Levitan, M. W. Enns, R. Morehouse, E. E. Michalak, and E. M. Tam
The Can-SAD Study: A Randomized Controlled Trial of the Effectiveness of Light Therapy and Fluoxetine in Patients With Winter Seasonal Affective Disorder
Am J Psychiatry,
May 1, 2006;
163(5):
805 - 812.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Paccagnella, A. Mauri, C. Baruffi, R. Berto, R. Zago, M. L. Marcon, D. Pizzolato, F. Fontana, L. Rizzo, M. Bisetto, et al.
Application Criteria of Enteral Nutrition in Patients With Anorexia Nervosa: Correlation Between Clinical and Psychological Data in a "Lifesaving" Treatment
JPEN J Parenter Enteral Nutr,
May 1, 2006;
30(3):
231 - 239.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Rush, M. H. Trivedi, S. R. Wisniewski, J. W. Stewart, A. A. Nierenberg, M. E. Thase, L. Ritz, M. M. Biggs, D. Warden, J. F. Luther, et al.
Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
N. Engl. J. Med.,
March 23, 2006;
354(12):
1231 - 1242.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Llorente and V. Urrutia
Diabetes, Psychiatric Disorders, and the Metabolic Effects of Antipsychotic Medications
Clin. Diabetes,
January 1, 2006;
24(1):
18 - 24.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Fisher
Treatment of Eating Disorders in Children, Adolescents, and Young Adults
Pediatr. Rev.,
January 1, 2006;
27(1):
5 - 16.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. D. Westanmo, J. Gayken, and R. Haight
Duloxetine: A balanced and selective norepinephrine- and serotonin-reuptake inhibitor
Am. J. Health Syst. Pharm.,
December 1, 2005;
62(23):
2481 - 2490.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. S. McIntyre, J. Z. Konarski, D. A. Mancini, K. A. Fulton, S. V. Parikh, S. Grigoriadis, L. A. Grupp, D. Bakish, M.-J. Filteau, C. Gorman, et al.
Measuring the severity of depression and remission in primary care: validation of the HAMD-7 scale
Can. Med. Assoc. J.,
November 22, 2005;
173(11):
1327 - 1334.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. J. Mann
The medical management of depression.
N. Engl. J. Med.,
October 27, 2005;
353(17):
1819 - 1834.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Yager, M. J. Devlin, K. A. Halmi, D. B. Herzog, J. E. Mitchell, P. S. Powers, and K. J. Zerbe
Guideline Watch: Practice Guideline for the Treatment of Patients With Eating Disorders, 2nd Edition
Focus,
October 1, 2005;
3(4):
546 - 551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Royal Australian and New Zealand College of Psychi
Australian and New Zealand Clinical Practice Guidelines for the Treatment of Anorexia Nervosa
Focus,
October 1, 2005;
3(4):
618 - 628.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus,
January 1, 2005;
3(1):
34 - 42.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. E. Aikens, D. E. Nease Jr, D. P. Nau, M. S. Klinkman, and T. L. Schwenk
Adherence to Maintenance-Phase Antidepressant Medication as a Function of Patient Beliefs About Medication
Ann. Fam. Med,
January 1, 2005;
3(1):
23 - 30.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Sayers
Biological Politics: Response and Afterword
Feminism Psychology,
August 1, 2004;
14(3):
448 - 452.
[PDF]
|
|
|
|
|
|
|
S. J. Bartels, A. R. Dums, T. E. Oxman, L. S. Schneider, P. A. Arean, G. S. Alexopoulos, and D. V. Jeste
Evidence-Based Practices in Geriatric Mental Health Care
Focus,
April 1, 2004;
2(2):
268 - 281.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Helgason, H. Tomasson, and T. Zoega
Antidepressants and public health in Iceland: Time series analysis of national data
The British Journal of Psychiatry,
February 2, 2004;
184(2):
157 - 162.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. L. Sohler, J. Walkup, D. McAlpine, C. Boyer, and M. Olfson
Antipsychotic Dosage at Hospital Discharge and Outcomes Among Persons With Schizophrenia
Psychiatr Serv,
September 1, 2003;
54(9):
1258 - 1263.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. S. Mehler
Bulimia Nervosa
N. Engl. J. Med.,
August 28, 2003;
349(9):
875 - 881.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Hay
Putting the research into practice
BMJ,
August 16, 2003;
327(7411):
381 - 381.
[Full Text]
|
|
|
|
|
|
|
B.-C. Ho, N. C. Andreasen, P. Nopoulos, S. Arndt, V. Magnotta, and M. Flaum
Progressive Structural Brain Abnormalities and Their Relationship to Clinical Outcome: A Longitudinal Magnetic Resonance Imaging Study Early in Schizophrenia
Arch Gen Psychiatry,
June 1, 2003;
60(6):
585 - 594.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. R. Patel, H. D. Pratt, and D. E. Greydanus
Treatment of Adolescents with Anorexia Nervosa
Journal of Adolescent Research,
May 1, 2003;
18(3):
244 - 260.
[Abstract]
[PDF]
|
|
|
|
|
|
|
H. D. Pratt, E. L. Phillips, D. E. Greydanus, and D. R. Patel
Eating Disorders in the Adolescent Population:: Future Directions
Journal of Adolescent Research,
May 1, 2003;
18(3):
297 - 317.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Caligor, M. Hamilton, H. Schneier, J. Donovan, B. Luber, and S. Roose
Converted Patients and Clinic Patients as Control Cases: a Comparison With Implications for Psychoanalytic Training
J Am Psychoanal Assoc,
March 1, 2003;
51(1):
201 - 220.
[Abstract]
[PDF]
|
|
|
|
|
|
|
I. M. Anderson
Drug treatment of depression: reflections on the evidence
Advan. Psychiatr. Treat.,
January 1, 2003;
9(1):
11 - 20.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Committee on Adolescence
Identifying and Treating Eating Disorders
Pediatrics,
January 1, 2003;
111(1):
204 - 211.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. S. Rome, S. Ammerman, D. S. Rosen, R. J. Keller, J. Lock, K. A. Mammel, J. O'Toole, J. M. Rees, M. J. Sanders, S. M. Sawyer, et al.
Children and Adolescents With Eating Disorders: The State of the Art
Pediatrics,
January 1, 2003;
111(1):
e98 - 108.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A. Remick
Diagnosis and management of depression in primary care: a clinical update and review
Can. Med. Assoc. J.,
November 26, 2002;
167(11):
1253 - 1260.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. A Furukawa, H. McGuire, and C. Barbui
Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review
BMJ,
November 2, 2002;
325(7371):
991 - 991.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
